A detailed history of Optimas Capital LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Optimas Capital LTD holds 59,865 shares of MRK stock, worth $7.53 Million. This represents 6.91% of its overall portfolio holdings.

Number of Shares
59,865
Previous 22,700 163.72%
Holding current value
$7.53 Million
Previous $2.47 Million 219.28%
% of portfolio
6.91%
Previous 2.47%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $4.21 Million - $4.9 Million
37,165 Added 163.72%
59,865 $7.9 Million
Q4 2023

Jan 22, 2024

BUY
$100.18 - $109.02 $42,977 - $46,769
429 Added 1.93%
22,700 $2.47 Million
Q3 2023

Oct 30, 2023

SELL
$102.95 - $114.33 $939,830 - $1.04 Million
-9,129 Reduced 29.07%
22,271 $2.29 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $3.41 Million - $3.72 Million
31,400 New
31,400 $3.62 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Optimas Capital LTD Portfolio

Follow Optimas Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimas Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Optimas Capital LTD with notifications on news.